Epstein-Barr virus vaccine - Cerus
Alternative Names: EBV vaccine - CerusLatest Information Update: 01 May 2007
At a glance
- Originator Cerus Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Epstein-Barr virus infections
Most Recent Events
- 14 Feb 2003 Phase-I clinical trials in Epstein-Barr virus infections in USA (unspecified route)